Shigehiko Kitano
Overview
Explore the profile of Shigehiko Kitano including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
497
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sugimoto M, Chujo S, Kato K, Shimura M, Kitano S, Kusuhara S, et al.
J Clin Med
. 2024 Dec;
13(23).
PMID: 39685795
: The object of this study was to determine the outcomes of treatments other than anti-vascular endothelial growth factor (VEGF) therapy for diabetic macular edema (DME) before and after the...
2.
Shimura M, Hirano T, Tsuiki E, Takamura Y, Morizane Y, Akiyama K, et al.
Retina
. 2024 Oct;
45(2):335-344.
PMID: 39423137
Purpose: To assess the real-world outcome of best-corrected visual acuity after 2-year intervention for treatment-naive diabetic macular edema since the approval of anti-vascular endothelial growth factor therapy. Methods: A total...
3.
Shimura M, Oh H, Ueda T, Kitano S, Mitamura Y, Sato J, et al.
Jpn J Ophthalmol
. 2024 Jul;
68(5):511-522.
PMID: 39083147
Purpose: To evaluate the 2-year efficacy, durability, and safety of faricimab in patients with diabetic macular edema (DME) in the YOSEMITE Japan subgroup. Study Design: YOSEMITE/RHINE (NCT03622580/NCT03622593) subgroup analysis: global,...
4.
Hirose A, Maeda Y, Goto A, Minami M, Kitano S, Uchigata Y
Diabetol Int
. 2023 Oct;
14(4):445.
PMID: 37781460
[This corrects the article DOI: 10.1007/s13340-023-00654-w.].
5.
Hirose A, Maeda Y, Goto A, Minami M, Kitano S, Uchigata Y
Diabetol Int
. 2023 Oct;
14(4):440-444.
PMID: 37781457
Aims: To find an index of glycemic exposure that predicts retinopathy by a simple regression setting regardless of duration in type 1 diabetes which might be useful for the care...
6.
Shimura M, Kitano S, Ogata N, Mitamura Y, Oh H, Ochi H, et al.
Jpn J Ophthalmol
. 2023 Mar;
67(3):264-279.
PMID: 36897413
Purpose: To evaluate efficacy, durability, and safety of faricimab in Japanese patients with diabetic macular edema (DME). Study Design: Subgroup analysis of 2 global, multicenter, randomized, double-masked, active-comparator-controlled, phase 3...
7.
Tobimatsu Y, Ogihara R, Endo N, Hirose A, Takeda R, Babazono T, et al.
Curr Eye Res
. 2022 Nov;
48(1):80-85.
PMID: 36331099
Purpose: To examine the effect of 0.1% bromfenac (BF) ophthalmic solution and 0.1% betamethasone (BM) ophthalmic solution on diabetic macular edema (DME). Methods: This was a prospective trial. Nineteen patients...
8.
Sugimoto M, Sampa K, Tsukitome H, Kato K, Matsubara H, Asami S, et al.
J Clin Med
. 2022 May;
11(10).
PMID: 35629076
In the original publication [...].
9.
Kusuhara S, Shimura M, Kitano S, Sugimoto M, Muramatsu D, Fukushima H, et al.
J Diabetes Investig
. 2022 Apr;
13(8):1339-1346.
PMID: 35389565
Aims/introduction: In older patients, the management of diabetic macular edema (DME) can be complicated by comorbidities, geriatric syndrome, and socioeconomic status. This study aims to evaluate the effects of aging...
10.
Sugimoto M, Sampa K, Tsukitome H, Kato K, Matsubara H, Asami S, et al.
J Clin Med
. 2022 Jan;
11(1).
PMID: 35011906
The aim of this study was to determine the prevalence and progression of diabetic retinopathy (DR) with hyperglycemic disorders during pregnancy (HDPs) in Japan between 2013 and 2018 using two...